MATTHEW STEFAN

Mr. MATTHEW STEFAN


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMATTHEW STEFAN
MATTHEW STEFAN
MSMatthew Sharp
Matthew Sharp
RGRaad Gheith
Raad Gheith
RLRyan Lowery
Ryan Lowery
JWJacob Wilson
Jacob Wilson
The ketogenic diet is a high-fat, very low-carbohydrate, moderate-protein diet that will induce a state of ketosis, but because of its restrictive nature, it may be difficult to adhere to, especially in adolescents. Supplementing with exogenous beta-hydroxybutyrate salts may induce a state of temporary ketosis without any undesirable side effects, thereby promoting the benefits of ketosis and minimizing adherence requirements to a ketogenic diet. To date, beta-hydroxybutyrate supplementation in healthy adolescents has not been explored. Therefore, the purpose of this study was to examine the safety of exogenous beta-hydroxybutyrate salt supplementation in a healthy adolescent population. In the present study, 22 healthy male and female adolescents consumed 3.75 g of beta-hydroxybutyrate salts or maltodextrin placebo twice daily for 90 days. Comprehensive blood safety analysis, bone densitometry, happiness and emotional intelligence surveys, and blood pressure were assessed at Pre, Day 45, and Day 90. There were no significant differences detected in subjects supplementing with beta-hydroxybutyrate salts, indicating that exogenous beta-hydroxybutyrate salts had no detrimental impact on fasting blood safety metrics, bone density, happiness, emotional intelligence, or blood pressure. We conclude that supplementing with exogenous beta-hydroxybutyrate salts is safe and well-tolerated by healthy adolescents.

28 September 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMATTHEW STEFAN
MATTHEW STEFAN
MSMatthew Sharp
Matthew Sharp
RGRaad Gheith
Raad Gheith
RLRyan Lowery
Ryan Lowery
COCharlie Ottinger
Charlie Ottinger
ABAouatef Bellamine
Aouatef Bellamine
L-carnitine tartrate has been shown to improve relatively short-term recovery among athletes. However, there is a lack of research on the longer-term effects in the general population. Objective: The primary objectives of this randomized double-blind, placebo-controlled trial were to evaluate the effects of daily L-carnitine tartrate supplementation for 5 weeks on recovery and fatigue. Method: In this study, eighty participants, 21- to 65-years-old, were recruited. Participants were split into two groups of forty participants each, a placebo, and a L-carnitine Tartrate group. Seventy-three participants completed a maintenance exercise training program that culminated in a high-volume exercise challenge. Results: Compared to placebo, L-carnitine tartrate supplementation was able to improve perceived recovery and soreness (p = 0.021), and lower serum creatine kinase (p = 0.016). In addition, L-carnitine tartrate supplementation was able to blunt declines in strength and power compared to placebo following an exercise challenge. Two sub-analyses indicated that these results were independent of gender and age. Interestingly, serum superoxide dismutase levels increased significantly among those supplementing with L-carnitine tartrate. Conclusions: These findings agree with previous observations among healthy adult subjects and demonstrate that L-carnitine tartrate supplementation beyond 35 days is beneficial for improving recovery and reducing fatigue following exercise across gender and age.

4 July 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMatthew Sharp
Matthew Sharp
Kazim SahinKazim Sahin
Kazim Sahin
MSMATTHEW STEFAN
MATTHEW STEFAN
COCEMAL ORHAN
CEMAL ORHAN
RGRaad Gheith
Raad Gheith
JWJacob Wilson
Jacob Wilson
The purpose of this study was to investigate the impact of antioxidant-rich marine phytoplankton supplementation (Oceanix, OCX) on performance and muscle damage following a cross-training event in endurance-trained subjects. Additionally, an animal model was carried out to assess the effects of varying dosages of OCX, with exercise, on intramuscular antioxidant capacity. Methods: In the human trial, endurance-trained subjects (average running distance = 29.5 ± 2.6 miles × week−1) were randomly divided into placebo (PLA) and OCX (25 mg) conditions for 14 days. The subjects were pre-tested on a one-mile uphill run, maximal isometric strength, countermovement jump (CMJ) and squat jump (SJ) power, and for muscle damage (creatine kinase (CK)). On Day 12, the subjects underwent a strenuous cross-training event. Measures were reassessed on Day 13 and 14 (24 h and 48 h Post event). In the animal model, Wistar rats were divided into four groups (n = 7): (i) Control (no exercise and placebo (CON)), (ii) Exercise (E), (iii) Exercise + OCX 1 (Oceanix, 2.55 mg/kg/day, (iv) Exercise + OCX 2 (5.1 mg/kg/day). The rats performed treadmill exercise five days a week for 6 weeks. Intramuscular antioxidant capacity (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px)) and muscle damage (CK and myoglobin (MYOB) were collected. The data were analyzed using repeated measures ANOVA and t-test for select variables. The alpha value was set at p < 0.05. Results: For the human trial, SJ power lowered in PLA relative to OCX at 24 h Post (−15%, p < 0.05). Decrements in isometric strength from Pre to 48 h Post were greater in the PLA group (−12%, p < 0.05) than in the OCX. Serum CK levels were greater in the PLA compared to the OCX (+14%, p < 0.05). For the animal trial, the intramuscular antioxidant capacity was increased in a general dose-dependent manner (E + Oc2 > E + Oc1 > E > CON). Additionally, CK and MYOB were lower in supplemented compared to E alone. Conclusions: Phytoplankton supplementation (Oceanix) sustains performance and lowers muscle damage across repeated exercise bouts. The ingredient appears to operate through an elevating oxidative capacity in skeletal muscle.

16 November 2022 in Journal of Science in Sport and Exercise
Verified
Journal Article
Open access
PDF file
MSMatthew Sharp
Matthew Sharp
COCharlie Ottinger
Charlie Ottinger
RGRaad Gheith
Raad Gheith
MSMATTHEW STEFAN
MATTHEW STEFAN
RLRyan Lowery
Ryan Lowery
JWJacob Wilson
Jacob Wilson
Purpose: This study compared the effects of offset loading (OSL) versus traditional loading (TDL) in the bench press exercise on pectoral muscle thickness and bench press strength over a 4-week mesocycle. Methods: Twenty male participants aged 18–45 years with at least 5 years of bench press experience and a bench press one-repetition maximum equal to or greater than their body mass were randomly assigned to OSL and TDL groups. Before and after the 4-week mesocycle, pectoral muscle thickness was assessed via ultrasonography and muscle strength was assessed by bench press one-repetition maximum. Effects were explored with two-way mixed ANOVA and non-clinical magnitude-based inferences. Results: No group-by-time interaction was detected for any variable (P > 0.05). When compared to small magnitudes, the pectoralis major muscle thickness changes were likely greater in OSL compared to TDL for the dominant (ES = 0.70; 87% likely greater) and nondominant pectoralis (ES = 0.77; 91% likely greater) as well as the sum of both pectorals (ES = 0.80; 92% likely greater). Similarly, a likely greater effect for absolute (ES = 0.57; 82% likely) and relative (ES = 0.67; 85% likely) bench press strength was seen with OSL. Conclusion: Magnitude-based inferences interpreted here support the notion that OSL may be an advantageous training modality to enhance pectoral muscle thickness and bench press strength.

3 June 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMATTHEW STEFAN
MATTHEW STEFAN
DGDavid Gundermann
David Gundermann
MSMatthew Sharp
Matthew Sharp
BJBrooke Jennings
Brooke Jennings
RGRaad H. Gheith
Raad H. Gheith
JWJacob Wilson
Jacob Wilson
(1) Background: Iron deficiency without anemia (IDWA) is a prevalent health concern in premenopausal women. Oral supplementation of iron may be a viable solution to improve blood-iron status in women; however, the effects of a high-dose iron-supplement regimen have been associated with gastrointestinal side effects. Therefore, the purpose of the present study was to evaluate the effectiveness of a low-dose liquid fermented iron-bisglycinate supplement (LIS) on improving blood-iron status in premenopausal women with IDWA without increasing constipation or gastrointestinal distress. (2) Methods: 85 premenopausal women with IDWA (ferritin < 70 ng/dL and hemoglobin > 11.0 g/dL) took a LIS (27 mg) or a placebo (PLA) for 8 weeks. Blood draws were taken at Wk0 and Wk8 of the study to measure serum-iron markers. In addition, surveys of gastrointestinal distress were administered at Wk0, Wk4, and Wk8 while the profile of mood states (POMS) was surveyed at Wk0 and Wk8. (3) Results: Compared to the placebo, the LIS was able to increase serum ferritin (p = 0.03), total serum iron (p = 0.03), and mean corpuscular volume (p = 0.02), while exhibiting no significant interaction in subjective gastrointestinal distress (p > 0.05). No significant effects were detected for POMS (p > 0.05). (4) Conclusions: Supplementing with LIS appears to improve blood-iron status without causing significant gastrointestinal distress in premenopausal women with IDWA.

12 December 2023 in Nutraceuticals
Verified
Journal Article
Open access
PDF file
RGRaad Gheith
Raad Gheith
MSMatthew Sharp
Matthew Sharp
MSMATTHEW STEFAN
MATTHEW STEFAN
COCharlie Ottinger
Charlie Ottinger
RLRyan Lowery
Ryan Lowery
JWJacob Wilson
Jacob Wilson
Geranylgeraniol (GG), an ingredient extracted from the South American annatto plant, has been shown to benefit bone and muscle health, is crucial in the biosynthesis of menaquinone-4 and coenzyme Q10, and has pain and inflammation reduction activities. However, no known studies to date have demonstrated the safety and impact of GG supplementation in humans. This 8-week, randomized, placebo-controlled, dose-escalated trial was conducted to determine the effect of GG on blood safety and hormone markers in healthy adults. Sixty-six males and females between 30 and 49 years of age were supplemented with either GG or a placebo (PLA) for 8 weeks, with dose escalation from 150 mg to 300 mg occurring after 4 weeks in the treatment group. Changes in complete blood count and comprehensive metabolic panels were analyzed for whole study groups (males and females) while changes in sex hormone panels were analyzed for males and females independently. There were no significant changes in complete blood count, comprehensive metabolic panel, progesterone, estradiol, sex–hormone binding globulin, or dihydrotestosterone (p > 0.05). An exploratory analysis of testosterone levels in a subgroup of males with baseline (Pre) total testosterone < 700 ng/dL (GG = 15; PLA = 13) demonstrated a significant increase (p < 0.05) from Pre to Week 8 in total-, free-, and bioavailable testosterone (+7.5%, +15.0%, and +14.8%, respectively). This study demonstrates that GG does not significantly change the composition of blood chemistry, hematology, or sex hormone profiles in adult males or females. Given the effects observed in the exploratory analysis in a subgroup of males, GG supplementation may be beneficial for testosterone enhancement in male populations subject to low testosterone (i.e., aging males and those with late-onset hypogonadism), but further research is needed.